Amyloid Beta Peptide N-Terminal Antibody – Mouse Monoclonal

Description: Mouse monoclonal antibody against N-terminal sequence of human amyloid beta peptides

background: Abeta40, Abeta42 and Abeta43 are different only at the few C-end amino acids. While the C-end amino acids showed no species-specificity in mammalians, the N-terminal amino acid sequences have minor discrepancies between difference species.
Amyloid beta peptides Abeta42 and Abeta40 have been investigated extensively for predicating Alzheimer's disease. A recent study on A Abeta43 in brain showed that Abeta43 is more fibrillogenic than the other amyloid beta peptides and may be useful as a biomarker or therapeutic target for Alzheimer's disease. Antibody to N-terminal sequence can bind to all the three amyloid beta peptides.

Small volumes of anti-amyloid beta peptide N-terminal antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS592392 is an antibody targeting amyloid beta peptide N-terminal. Also known as mAb anti-human amyloid beta peptide N-terminal. Reactive in Human. Host: Mouse.